May 03, 2017 - The hits just keep on coming for Teva and its shareholders, but relief may be around the corner.
Aug 07, 2017 - I went long Teva at ~35 USD due to its strong generics business and the possible synergies of 1.4 billion USD due to the Actavis acquisition.Unfortunately, management failed to set realistic expectati
Apr 25, 2017 - Two years ago, I wrote an article criticizing Teva for its lack of innovation. I believed that it was very dependent on Copaxone.Two years have passed, and while Teva still can't replace the revenues
May 16, 2017 - Coatings specialist doesn't seem to know how to take "No" for an answer.
Sep 07, 2018 - Names on the move ahead of the open.
May 11, 2017 - The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan.
Dec 27, 2017 - Management missteps and tectonic shifts in the pharmaceutical business have battered Teva, The New York Times reports.
Nov 28, 2018 - Names on the move ahead of the open.
Sep 14, 2017 - Teva Pharmaceuticals finally had some good news for investors.Three positive press releases in two days might indicate that the company is stabilizing.I like the news and the decisiveness of the board
Dec 14, 2017 - Teva Pharmaceutical said it will slash 14,000 jobs around the world in an attempt to stabilize the company.